1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
20.59%
Revenue growth under 50% of FSLR's 92.60%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
62.44%
Gross profit growth under 50% of FSLR's 217.60%. Michael Burry would be concerned about a severe competitive disadvantage.
-8.26%
Negative EBIT growth while FSLR is at 130.61%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
0.07%
Operating income growth under 50% of FSLR's 130.61%. Michael Burry would be concerned about deeper cost or sales issues.
-12.95%
Negative net income growth while FSLR stands at 124.69%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.97%
Negative EPS growth while FSLR is at 124.62%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.97%
Negative diluted EPS growth while FSLR is at 124.42%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
5.99%
Share count expansion well above FSLR's 0.40%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.99%
Diluted share count expanding well above FSLR's 1.32%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Dividend reduction while FSLR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
67.36%
OCF growth under 50% of FSLR's 2755.37%. Michael Burry might suspect questionable revenue recognition or rising costs.
56.05%
FCF growth under 50% of FSLR's 292.70%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
440.15%
10Y revenue/share CAGR under 50% of FSLR's 13982.71%. Michael Burry would suspect a lasting competitive disadvantage.
117.43%
5Y revenue/share CAGR under 50% of FSLR's 936.18%. Michael Burry would suspect a significant competitive gap or product weakness.
53.55%
3Y revenue/share CAGR at 50-75% of FSLR's 75.48%. Martin Whitman would question if the firm lags behind competitor innovations.
-134.86%
Negative 10Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-652.07%
Negative 5Y OCF/share CAGR while FSLR is at 2734.46%. Joel Greenblatt would question the firm’s operational model or cost structure.
-1310.38%
Negative 3Y OCF/share CAGR while FSLR stands at 1732.47%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-97.51%
Negative 10Y net income/share CAGR while FSLR is at 1416.44%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-898.56%
Negative 5Y net income/share CAGR while FSLR is 108.84%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-550.73%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
13.52%
Below 50% of FSLR's 483.75%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-32.09%
Negative 3Y equity/share growth while FSLR is at 41.81%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-45.25%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-12.78%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.89%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-12.10%
We have a declining book value while FSLR shows 4.33%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
20.41%
We have some new debt while FSLR reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-15.68%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-18.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.